VCEL

#1744
Vericel Corporation
35.6800
-0.31%
Secteur:
Base:
Devise de Profit:
Range quotidien
35.6800
35.6800
Range Annuel
33.5800
43.0000
Changement quotidien
-0.31%
Changement Mensuel
-3.02%
Evolution sur 6 mois
-1.84%
Changement Annuel
-1.84%
Clôture Précédente
35.7900
Open
35.6800
Bid
Ask
Low
35.6800
High
35.6800
Volume
88
Open full chart

Financials

Overview Relevé Statistics Dividends
Quarterly Annual
  • Market Capitalization 1.7961 B
  • Employee 357
  • Founded 1989
  • CEO Nick Colangelo
  • Website www.vcel.com
  • Headquarter Michigan, United States
  • FIGI BBG000BDCM24
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
112.53
Price to sales ratio
—
Dividends per share
—
Dividend yield %
—

Vericel Corporation

Vericel Corporation is a publicly traded American biopharmaceutical company which was known prior to October 2014 as Aastrom Bio. Aastrom Bio was formed in 1989 in Ann Arbor, Michigan. In the spring of 2014, Aastrom Bio acquired Sanofi's cell therapy and regenerative medicine business which Sanofi had acquired when purchasing Genzyme in 2011. This transformed Aastrom in several ways: it increased the employee count by 8-fold and provided a revenue stream and products to market, which it had not had before. In October 2014, the company changed its name from Aastrom Bio to Vericel and relocated its headquarters from Ann Arbor, Michigan to Cambridge, Massachusetts.

Nouvelles